Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionVise Technologies, Inc.
Latest Disclosed Ownership19,503 shares
Latest Disclosed Value $ 6,383,661
Vise Technologies, Inc. ownership in AMGN / Amgen Inc.

On April 21, 2026 - Vise Technologies, Inc. filed a 13F-HR form disclosing ownership of 19,503 shares of Amgen Inc. (MX:AMGN) valued at $6,383,661 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 19,503 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F AMGEN COM 031162100 19,503 0 0.00 6,384 0.00 0.1254
2026-02-11 2025-12-31 13F AMGEN COM 031162100 19,503 7,779 66.35 6,384 92.96 0.1251
2025-11-13 2025-09-30 13F AMGEN COM 031162100 11,724 -3,658 -23.78 3,309 -22.96 0.1231
2025-08-07 2025-06-30 13F AMGEN COM 031162100 15,382 9,800 175.56 4,295 195.32 0.1773
2025-02-18 2024-12-31 13F AMGEN COM 031162100 5,582 1,406 33.67 1,455 8.10 0.1212
2024-11-13 2024-09-30 13F AMGEN COM 031162100 4,176 306 7.91 1,346 11.25 0.1712
2024-08-02 2024-06-30 13F AMGEN COM 031162100 3,870 -394 -9.24 1,209 -0.25 0.2122
2024-05-15 2024-03-31 13F AMGEN COM 031162100 4,264 -1,457 -25.47 1,212 -26.41 0.2388
2024-02-08 2023-12-31 13F AMGEN COM 031162100 5,721 -1,107 -16.21 1,648 -10.25 0.3546
2023-10-31 2023-09-30 13F AMGEN COM 031162100 6,828 1,021 17.58 1,835 42.36 0.4511
2023-08-08 2023-06-30 13F AMGEN COM 031162100 5,807 924 18.92 1,289 9.24 0.3122
2023-05-10 2023-03-31 13F AMGEN COM 031162100 4,883 -761 -13.48 1,180 -20.38 0.3111
2023-02-10 2022-12-31 13F AMGEN COM 031162100 5,644 1,975 53.83 1,482 79.20 0.4640
2022-11-14 2022-09-30 13F AMGEN COM 031162100 3,669 48 1.33 827 -6.13 0.3116
2022-08-15 2022-06-30 13F AMGEN COM 031162100 3,621 -3 -0.08 881 0.57 0.3419
2022-06-08 2022-03-31 13F AMGEN COM 031162100 3,624 1,091 43.07 876 53.68 0.3292
2022-06-07 2021-12-31 13F AMGEN COM 031162100 2,533 2,533 570 0.1543
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.